Olema Pharmaceuticals Files 8-K
Ticker: OLMA · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1750284
| Field | Detail |
|---|---|
| Company | Olema Pharmaceuticals, INC. (OLMA) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Regulation FD
TL;DR
Olema Pharma filed a routine 8-K, no major news.
AI Summary
Olema Pharmaceuticals, Inc. filed an 8-K on March 5, 2025, to report information under Regulation FD and to file financial statements and exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Olema Pharmaceuticals is fulfilling its regular reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not contain any new material information that would impact the company's risk profile.
Key Players & Entities
- Olema Pharmaceuticals, Inc. (company) — Registrant
- March 05, 2025 (date) — Date of earliest event reported
- 780 Brannan Street, San Francisco, California 94103 (address) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing by Olema Pharmaceuticals?
The 8-K filing is to report information under Regulation FD Disclosure and to file Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on March 05, 2025.
What is Olema Pharmaceuticals' principal executive office address?
The principal executive offices are located at 780 Brannan Street, San Francisco, California 94103.
What is Olema Pharmaceuticals' telephone number?
The company's telephone number is (415) 651-3316.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding Olema Pharmaceuticals, Inc. (OLMA).